United Therapeutics Corporation to Report Fourth Quarter and Annual 2017 Financial Results Before the Market Opens on Wednesday, February 21, 2018
|
|
| [14-February-2018] |
|
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results before the market opens on Wednesday, February 21, 2018. United Therapeutics will host a teleconference on Wednesday, February 21, 2018, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using access code: 2296917. This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm. [uthr-g] About United Therapeutics United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.
SOURCE United Therapeutics Corporation |
||
Company Codes: NASDAQ-NMS:UTHR |